Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer Awareness Day on September 9, 2024
STAA Stock | USD 28.06 0.49 1.72% |
About 63% of all STAAR Surgical's investors are looking to take a long position. The analysis of overall sentiment of trading STAAR Surgical stock suggests that some investors are interested at this time. The current market sentiment, together with STAAR Surgical's historical and current headlines, can help investors time the market. In addition, many technical investors use STAAR Surgical stock news signals to limit their universe of possible portfolio assets.
STAAR |
BOSTON HOUSTON, Texas, September 03, 2024--Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, and the STAAR Ovarian Cancer Foundation today announced the first Low-Grade Serous Ovarian Cancer Awareness Day or LGSOC Awareness Day on September 9, 2024.
Read at finance.yahoo.com
STAAR Surgical Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards STAAR Surgical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
STAAR Surgical Fundamental Analysis
We analyze STAAR Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STAAR Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STAAR Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
STAAR Surgical is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
STAAR Surgical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with STAAR Surgical stock to make a market-neutral strategy. Peer analysis of STAAR Surgical could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics with similar companies.
Peers
STAAR Surgical Related Equities
ANGO | AngioDynamics | 2.34 | ||||
MBOT | Microbot Medical | 1.02 | ||||
RGEN | Repligen | 0.47 | ||||
COO | Cooper Companies, | 0.23 | ||||
RMD | ResMed | 0.17 | ||||
HAE | Haemonetics | 0.08 | ||||
WST | West Pharmaceutical | 0.14 | ||||
ATR | AptarGroup | 0.27 | ||||
BDX | Becton Dickinson | 0.55 | ||||
NVST | Envista Holdings | 0.81 | ||||
MMSI | Merit Medical | 0.88 | ||||
HOLX | Hologic | 0.92 | ||||
ICUI | ICU Medical | 5.99 |
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |